medigraphic.com
ISSN 2448-8909 (Print)

2019, Number 5

<< Back Next >>

Med Crit 2019; 33 (5)

Cardiogenic shock: from definition to the approach

Garnica CCE, Rivero SE, Domínguez CG

Language: Spanish
References: 29
Page: 251-258
PDF size: 296.26 Kb.


ABSTRACT

Cardiogenic shock (CSh) is the major catastrophe of acute myocardial infarction (AMI) and heart disease in general. It is defined as a state in which cardiac output (CO) is inefficient to perfuse and oxygenate tissues, which is why it manifests with signs of tissue hypoperfusion and capillary congestion. Although the latest guidelines do not require diagnosis with hemodynamic measures, relying only on the clinical can generate errors up to 30%. The causes are divided into ischemic (AMI) and non-ischemic, with the former being the most common. Despite the appearance of new mechanical devices, coupled with medical support, it has only shown the improvement of outcomes with endovascular therapies.


REFERENCES

  1. Thiele H, Ohman EM, Desch S, Eitel I, De Waha S. Management of cardiogenic shock. European Heart Journal. 2015;36:1223-1230.

  2. Tewelde SZ, Liu SS, Winters ME. Cardiogenic shock. Cardiol Clin. 2018;36:53-61.

  3. Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock. Circulation. 2017;136(16):e232-e268.

  4. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-2200.

  5. Jackson G, Cullum P, Pastellopoulos A, Macarthur A, Jewitt D. Intra-aortic balloon assistance in cardiogenic shock after myocardial infarction or cardiac surgery. Br Heart J. 1977;39(6):598-604.

  6. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341(9):625-634.

  7. Hurtado BA, Santome JA, Fernandez BC, Cárdenas LM. Infarto agudo del miocardio con choque cardiogénico. Arch Inst Cardiol Mex. 1984;54:121-129.

  8. Martínez-Sánchez C, Chuquiure-Valenzuela E, Flores-Ramírez R, García-López S, Arias-Mendoza A, González-Pacheco H, et al. Choque cardiogénico. Las variables de mortalidad. Gac Méd Méx. 2005;141(5):395-400.

  9. TRIUMPH Investigators, Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock the TRIUMPH randomized controlled trial. JAMA. 2007;297(15):1657-1666.

  10. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287-1296.

  11. Thiele H, Desch S, Piek JJ, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, et al. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: design and rationale of CULPRIT-SHOCK trial. Am Heart J. 2016;172:160-169.

  12. Hellerstein HK, Brofman BL, Caskey WH. Shock accompanying myocardial infarction: Treatment with pressor amines. Amer Heart J. 1952;44(3):407-427.

  13. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction. a population-based perspective. Circulation. 2009;119(9):1211-1219.

  14. Reynolds HR, Hochman JS. Cardiogenic Shock. Circulation. 2008;117(5):686-697.

  15. Forrester JS, Diamond GA, Swan HJ. Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol. 1977;39(2):137-154.

  16. Gidwani UK, Mohanty B, Chatterjee K. The pulmonary artery catheter. Cardiol Clin. 2013;31:545-565.

  17. Cooper HA, Panza JA. Cardiogenic shock. Cardiol Clin. 2013;31(4):567-580.

  18. Reynolds HR, Anand SK, Fox JM, Harkness S, Dzavik V, White HD, et al. Restrictive physiology in cardiogenic shock: observations from echocardiography. Am Heart J. 2006;151(4):890.e9-e15.

  19. McLean AS. Echocardiography in shock management. Crit Care. 2016;20:275.

  20. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779-789.

  21. Nieminen MS, Buerke M, Cohen-Solál A, Costa S, Édes I, Erlikh A, et al. The role of levosimendan in acute heart failure complicating acute coronary syndrome: a review and expert consensus opinion. Int J Cardiol. 2016;218:150-157.

  22. Tarvasmäki T, Lassus J, Varpula M, Sionis A, Sund R, Køber L, et al. Current real-life use of vasopressors and inotropes in cardiogenic shock-adrenaline use is associated with excess organ injury and mortality. Crit Care. 2016;20(1):208.

  23. Freedman RJ. The intra-aortic balloon pump system: current roles and future directions. J Cardiol. 1991;6:313.

  24. Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, et al. Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience. J Am Coll Cardiol. 1995;26:668-674.

  25. Duvernoy CS, Bates ER. Management of cardiogenic shock. J Intensive Care Med. 2005;20(4):188-198.

  26. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119-177.

  27. White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the should we emergently revascularize occluded coronaries for cardiogenic shock (SHOCK) trial. Circulation. 2005;112(13):1992-2001.

  28. Chou TM, Amidon TM, Ports TA, Wolfe CL. Cardiogenic shock: thrombolysis or angioplasty? J Intensive Care Med. 1996;11(1):37-48.

  29. Bentzer P, Griesdale DE, Boyd J, MacLean K, Sirounis D, Ayas NT. Will this hemodynamically unstable patient respond to a bolus of intravenous fluids? JAMA. 2016;316(12):1298-1309.




2020     |     www.medigraphic.com